BioSpace News Archive

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announces the completion of its new North America headquarters at 510 Carnegie Center in Princeton, NJ.

Anixa Biosciences, Inc. today announced that the Canadian Intellectual Property Office has issued Canadian Intellectual Property Office has issued Canadian Patent 2,989,807 covering Anixa’s novel Chimeric Antigen Receptor-T cell (CAR-T) cancer treatment technology.

Verismo Therapeutics today announced that Dr. Mala Talekar, MBBS, DABP, DNB has joined the company as Vice President of Clinical Development.

Omnicell, Inc. today announced it has increased its number of board seats from 9 to 10, and has appointed Kaushik “Bobby” Ghoshal to fill the newest seat as an independent director of Omnicell’s Board of Directors, effective immediately.

Scientists from the Allen Institute for Neural Dynamics, a division of the Allen Institute, launched the world’s first completely open- and crowd-sourced neuroscience experiment—inviting researchers from around the world to publicly design a shared experiment that will run on the Allen Brain Observatory, as part of the Institute’s OpenScope program.

Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 27, 2023.

Kytopen, a leading biotechnology company specializing in scalable gene editing platforms, today announces a strategic collaboration with Rice University’s prestigious Omid Veiseh Laboratory.

Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1M Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal intraocular pressure.

PHM announces the publication of a case report summarizing a patient’s complete response to an innovative treatment for prostate cancer.

Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of the latest version of DRAGEN™ software for analysis of next-generation sequencing data.